Originally published by our sister publication Infectious Disease Special Edition
By IDSE News Staff
A new bill introduced to the U.S. Senate aims to increase funding and access for hepatitis C virus (HCV) treatment in the United States. The “Cure Hepatitis C Act” would connect HCV patients to treatment through establishing a voluntary drug subscription model.
The model aims to connect individuals with HCV to treatment. Only 34% of people with diagnosed HCV in the United States